Progyny Inc.
BioSniper Score
Based on 3 of 6 signals
Limited data coverage
Market Cap
$2.04B
Cash Runway
19.2 mo
Lead Asset
—
Next Catalyst
—
Go deeper on Progyny Inc. with Spotter
Ask follow-up questions and run a full multi-agent deep dive on PGNY — live, with citations.
Score breakdownBased on 3 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
19.2 months
D/E 0.59 · 8% dilution
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
0 buys · 15 sells (180d)
Key Financialsas of March 31, 2026
Cash
$133.6M
Quarterly Burn
$47.7M
Revenue
$328.5M
Free Cash Flow
$39.6M
Total Liabilities
$259.0M
Shareholders Equity
$439.3M
Current Ratio
2.13
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Commercialization & Governance
Commercialization
- Partnerships
- Benefits consultants, channel partners, and health plan partners
- Launch Markets
- United States
- Commercial Strategy
- We sell our solutions through our sales organization and, in many cases, we leverage our relationships with top benefits consultants, channel partners and health plan partners to establish relationships with potential clients. Our sales team has broad experience in health benefits management and extensive long-term relationships with industry participants and benefits executives at large employers. Our sales team is organized principally by geography and account size and is responsible for identifying potential clients and managing the overall sales.
Governance
- Board Size
- 11
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
290
Total value held
$1.31B
| Holder | Shares | Value |
|---|---|---|
| blackrock, inc. | 11,998,467 | $203.7M |
| fmr llc | 6,500,819 | $110.4M |
| vanguard portfolio management llc | 5,292,028 | $89.9M |
| vanguard capital management llc | 3,481,339 | $59.1M |
| state street corp | 3,080,293 | $52.3M |
| ameriprise financial inc | 2,825,331 | $48.0M |
| fort washington investment advisors inc /oh/ | 2,693,393 | $45.7M |
| morgan stanley | 2,287,617 | $38.8M |
| wellington management group llp | 2,287,381 | $38.8M |
| geode capital management, llc | 2,042,965 | $34.7M |
Showing top 10 of 290 institutional holders of Progyny Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
Who is the CEO of Progyny Inc.?
Mr. Peter Anevski CPA is the chief executive officer of Progyny Inc. (PGNY).
Where is Progyny Inc. headquartered?
Progyny Inc. (PGNY) is headquartered in New York, NY, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.
Get the full picture on Progyny Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.